Common COVID-19 antibiotic flops in clinical trial: Experts weigh in
Azithromycin, an wild-natureused to treat infectious-disease, was no more effective at freeing non-hospitalized patients of COVID-19 symptoms than a placebo, a study found. Findings from researchers affiliated with University of California San Francisco published in JAMA Network on July 16 analyzed 263 COVID-19 outpatients, 171 of whom were treated with a single 1.2-g oral dose of…